CureVac hit hard as its COVID jab fails to make the gradeCureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its Share XCureVac hit hard as its COVID jab fails to make the gradehttps://pharmaphorum.com/news/curevac-hit-hard-as-its-covid-jab-fails-to-make-the-grade/
UK booster trial will test value of third COVID jab doseAll seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will Share XUK booster trial will test value of third COVID jab dosehttps://pharmaphorum.com/news/uk-booster-trial-will-test-value-of-third-covid-jab-dose/
UK targets COVID-19 variants with new order for CureVac jabThe UK has agreed a 50 million-dose order for a COVID-19 vaccine with German biotech CureVac to support Share XUK targets COVID-19 variants with new order for CureVac jabhttps://pharmaphorum.com/news/uk-targets-covid-19-variants-with-new-order-for-curevac-jab/
Bayer joins the COVID-19 vaccine push, backing CureVac shotShortly after launching large-scale trials of its COVID-19 vaccine candidate, CureVac has the partner it will need to Share XBayer joins the COVID-19 vaccine push, backing CureVac shothttps://pharmaphorum.com/news/bayer-joins-the-covid-19-vaccine-push-backing-curevacs-shot/
BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fundIn May, Germany pledged to provide up to €750 million ($889 million) in funding to support vaccines against Share XBioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fundhttps://pharmaphorum.com/news/biontech-curevac-claim-bulk-of-germanys-e750m-covid-19-vaccines-fund/
UK announces COVID-19 vaccine deals with BioNTech/Pfizer and ValnevaThe UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses Share XUK announces COVID-19 vaccine deals with BioNTech/Pfizer and Valnevahttps://pharmaphorum.com/news/uk-announces-covid-19-vaccine-deals-with-biontechl-pfizer-and-valneva/
CureVac claims €75m in EU funding for mRNA COVID-19 vaccineGerman vaccine firm CureVac has been awarded a €75 million loan from the European Investment Bank to boost Share XCureVac claims €75m in EU funding for mRNA COVID-19 vaccinehttps://pharmaphorum.com/news/curevac-claims-e75m-in-eu-funding-for-mrna-covid-19-vaccine/
Trump tried to secure CureVac coronavirus vaccine for US only – reportsThe ugly side of the coronavirus outbreak continues to dominate the news, amid reports that the Trump administration Share XTrump tried to secure CureVac coronavirus vaccine for US only – reportshttps://pharmaphorum.com/news/trump-tried-to-secure-coronavirus-vaccine-for-us-only-reports/
Lilly joins cancer vaccine race with CureVac allianceLilly has signed a deal with CureVac to develop up to five next-generation cancer vaccines which use messenger Share XLilly joins cancer vaccine race with CureVac alliancehttps://pharmaphorum.com/news/lilly-joins-cancer-vaccine-race-curevac-alliance/
